
Colorectal cancer is the second most common cancer. New treatments tend to be in high demand because current treatment options offer limited efficacy and can be ineffective in up to 70% of patients, in part due to genetic variation, rendering personalized medicine to be increasingly important.
Argonaut Therapeutics plans to reboot the cancer cell so that it undergoes the body’s natural cell death process, known as apoptosis. Essentially, their therapies will target a “switch” that p...
More